Why the study?
Does cyclosporin A affect contractile activity and cytoskeleton organization in chick embryo cardiomyocytes?
Does cyclosporin A affect contractile activity and cytoskeleton organization in chick embryo cardiomyocytes?
Cyclosporin A directly affects the contractile activity, morphology, and cytoskeleton architecture of heart cells in vitro.
Answers are grounded in this paper and cite their sources.
CsA alters chick cardiomyocyte contractility and cytoskeleton in vitro at therapeutic levels; leaves open relevance to human cardiotoxicity or clinical practice.
The effects of cyclosporin A (CsA), a clinically used immunosupressive drug, on contractile activity of chick cardiomyocytes grown as small aggregates or explants suspended on a network of elastic glass fibres or cultured in a monolayer were analysed in vitro with computer-aided image cytometry methods. At therapeutic concentrations (200-1500 ng/mL), CsA induced changes in the frequency and amplitude of the beating activity of cardiomyocytes 15 min after application. Longer treatment of cardiomyocytes, for 20-24 h, additionally induced changes in their shape and cytoskeleton organization (F-actin and alpha-actinin distribution). These results indicate that CsA is able to affect directly the contractile activity, morphology, and cytoskeleton architecture of heart cells.
No takes yet. Share an insight, caveat, or question.
Kołcz et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: